Lund University is celebrating 350 years.


Javascript is not activated in your browser. This website needs javascript activated to work properly.

Vasopressin induces endolymphatic hydrops in mouse inner ear, as evaluated with repeated 9.4 T MRI.

  • Eva Degerman
  • René in 't Zandt
  • Ann-Kristin Holmén-Pålbrink
  • Måns Magnusson
Publishing year: 2015
Language: English
Pages: 119-124
Publication/Series: Hearing Research
Volume: 330
Issue: Part A
Document type: Journal article
Publisher: Elsevier

Abstract english

From histopathological specimens, endolymphatic hydrops has been demonstrated in association with inner ear disorders. Recent studies have observed findings suggestive of hydrops using MRI in humans. Previous studies suggest that vasopressin may play a critical role in endolymph homeostasis and may be involved in the development of Ménière's disease. In this study we evaluate the effect of vasopressin administration in vivo in longitudinal studies using two mouse strains. High resolution MRI at 9.4 T in combination with intraperitoneally delivered Gadolinium contrast, was performed before and after chronic subcutaneous administration of vasopressin via mini-osmotic pumps in the same mouse. A development of endolymphatic hydrops over time could be demonstrated in C57BL6 mice (5 mice, 2 and 4 weeks of administration) as well as in CBA/J mice (4 mice, 2 weeks of administration; 6 mice, 3 and 4 weeks of administration). In most C57BL6 mice hydrops developed first after more than 2 weeks while CBA/J mice had an earlier response. These results may suggest an in vivo model for studying endolymphatic hydrops and corroborates the future use of MRI as a tool in the diagnosis and treatment of inner ear diseases, such as Ménière's disease. MRI may also be developed as a critical tool in evaluating inner ear homeostasis in genetically modified mice, to augment the understanding of human disease. This article is part of a Special Issue entitled .


  • Otorhinolaryngology


  • Insulin Signal Transduction
  • ISSN: 0378-5955
E-mail: ann-kristin [dot] holmen-palbrink [at] med [dot] lu [dot] se

Biomedical analyst

Insulin Signal Transduction

+46 46 222 85 87

BMC C1109b


Lund University Diabetes Centre, CRC, SUS Malmö, Entrance 72, House 91:12. SE-205 02 Malmö. Telephone: +46 40 39 10 00